Doni Bloomfield
Alexion skids as muscle drug trial fails to meet primary goal
WASHINGTON - Alexion Pharmaceuticals Inc. fell the most in six years after the company’s drug for a rare neuromuscular disease failed to meet its...
Amgen bests Regeneron in patent fight over cholesterol drugs
Amgen Inc. won a legal victory over Regeneron Pharmaceuticals Inc. in an intellectual property battle over their cholesterol-reducing drugs. Regeneron said it would appeal...
Amgen posts profit that tops estimates, raises guidance
SAN FRANCISCO - Biotechnology giant Amgen Inc. posted third- quarter earnings that topped analysts’ estimates, driven by higher drug sales, and raised its forecast...
UnitedHealth raises 2015 forecast while medical costs weigh
NEW YORK - UnitedHealth Group Inc., the biggest U.S. health insurer, raised its full-year forecast after saying that profit gained in the second quarter,...
UnitedHealth beats estimates as Optum consulting sales climb
NEW YORK - UnitedHealth Group Inc., the biggest U.S. health insurer by sales, reported fourth-quarter profit that beat analysts’ estimates as revenue climbed in...
Retail medical moving in to vacancies left as video stores disappear
NEW YORK - With video stores and retailers closing their doors, retail real estate has had a tough half-decade. The cure? Urgent care clinics.
The...
Fight over $1,100 Hepatitis C pills awaits next move by CVS
NEW YORK - Gilead Sciences Inc. may finally be forced to offer a lower price for its $94,500 hepatitis C drug.
The biotechnology company could...
Comcast profit beats estimates as more broadband customers added
NEW YORK - Comcast Corp., the U.S. cable company awaiting regulatory approval to buy Time Warner Cable Inc., reported profit that beat estimates as...
- Featured Event -
